80
Participants
Start Date
November 1, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Probiotic Blend Oral Tablet
In our study, forty pregnant women were randomly assigned to the probiotic group, and the rest were assigned to the control group. After enrollment, pregnant women in the probiotic group received a combination of living Bifidobacterium longum (5 #106 CFU) by Neimengu Shuangqi Pharmaceutical Co., Ltd. Pregnant individuals in the probiotic group were administered four tablets three times a day (2 g/d) for seven days before surgery until the fourth day after surgery.
RECRUITING
Zhe Li, Guangzhou
Third Affiliated Hospital, Sun Yat-Sen University
OTHER